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Lung cancer, is the leading cause of cancer death in the United States for both men and 
women, and as such, represents a tremendous burden on the healthcare system. Survival 
rates have remained relatively unchanged over the past forty years, yet we seem to be on 
the verge of a paradigm shift as a result of advances in early screening, diagnosis and 
better treatment modalities. Lung cancer is different from all other cancers in that 90% of 
lung cancer cases can be attributed to the conscious behavioral risk factor of smoking, 
either currently or previously engaged in by the patient. Funding and research has been 
limited in terms of identifying the unique characteristics and needs of these patients, their 
physicians and their caregivers. Ifsurvival rates improve dramatically, these patients will 
be managed chronically rather than acutely in the near future. When this occurs, a lung 
cancer treatment model for the future must be developed in order to more successfully 
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prepare the market place for adapting to these unique patients and their providers who 
will be operating in a chronic rather than acute care environment. Prior to the 
development of such a model, the need exists to first develop a comprehensive 
information map identifying knowledge and knowledge gaps with regards to these 
patients and providers and their healthcare interactions and individualized needs. 
Productive patient provider interactions are critical for successful chronic disease 
management, and therefore several questions must be answered as they relate to treating 
lung cancer in a more chronic versus acute environment. 
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INTRODUCTION 
Lung cancer represents only 13% of all new cancer diagnoses, yet it is the leading 
cause of cancer death in the US for both men and women, accounting for almost 30% of 
all cancer deaths (Lung Cancer Alliance, pI). Five year survival rates for lung cancer are 
extraordinarily low, at less than fifteen percent, due to the fact that very few cases are 
diagnosed at an early stage, local disease, with no lymph node involvement. Almost 70% 
of all new lung cancers are diagnosed at very late stages of the disease, stage IIIb or stage 
IV, and sutvival rates today are not dramatically different than they were in the early 
1970's despite increases in survival rates for most other major cancers (Lung Cancer 
Alliance, pI). The number of deaths each year from breast cancer, prostate cancer, colon 
cancer, liver cancer, kidney cancer and melanoma combined will not surpass the number 
of deaths each year from lung cancer (Lung Cancer Alliance, pI). 
The medical costs alone for lung cancer are almost $5 billion annually (Lungusa, 
p2). The American Cancer Society (2006) estimated that there would be 174,470 new 
cases of lung cancer diagnosed and that there would be 162,460 lung cancer related 
deaths last year. As with most cancers, there is a tremendous disparity with regards to 
lung cancer diagnoses, with a disproportionate impact on minorities and those with a 
lower socioeconomic status. African American men are 500/0 more likely than white men 
to develop lung cancer. The incidence rate of lung cancer is equal for African American 
women and white women, although the rates of smoking are much lower in the former 
group (American Cancer Society, 2006). African Americans have both increased 
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incidence rates as well as lower survival rates regardless of the stage in which diagnosis 
is made, making the disparity for this group even more pronounced (NCI, 2004). 
Prevention and early detection are key to reducing costs and the burden of illness. 
Twice as many women will die from lung cancer compared to breast cancer, and three 
times as many men will die from lung cancer compared to prostate cancer, and yet there 
are currently no screening guidelines from the American Cancer Society related to early 
detection of lung cancer in asymptomatic individuals (Lung Cancer Alliance, pI). The 
fact that five year survival rates increase to almost 500/0 when a diagnosis is made early, 
gives a strong push towards developing new screening tests, molecular markers, and 
genetic breakthroughs to improve early detection as well as surgical or treatment 
expectations for these patients. These advances, if successful, are likely to make early 
diagnosis and more effective treatments a reality in the near future. 
Molecular and cellular epidemiological research has focused on improving our 
ability to understand the histologic changes that take place over the course of time, 
leading from a normal healthy bronchial pathway to a malignant lung cancer cell. These 
efforts are aimed at predicting not only which agents will cause cancer and the sequence 
of events that will take place morphologically, but at identifying which patients are 
genetically more predisposed to developing lung cancer in the presence or absence of 
those identified agents and causal factors (Alberg, 2005). Fifteen years ago, the Early 
Lung Cancer Action Project assessed the impact of an early diagnosis in smokers who 
underwent annual spiral computed tomography - CT screening (Henschke, CI et ai, 
1999). They found that 800/0 of patients diagnosed with lung cancer following annual CT 
screening had early stage I cancer (Henschke, CI., et ai, 2004). Later follow up studies 
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with these patients (Henschke, CI., et al2006) found that those who were diagnosed with 
stage I cancer, had improved ten year survival rates that were as high as 88%; and that 
all patients diagnosed with lung cancer, regardless of tumor stage, had a ten year survival 
rate of approximately 80%. Based on the screening specificity seen in this trial with high 
risk yet asymptomatic individuals, which was equal to or better than the specificity for 
breast cancer screening via mammography (Henschke, CI., et a12006), it still remains 
controversial as to why CT screening at less than $200 per person is not part of a routine 
guideline. This remains a possibility in the near future that could have profound 
implications for patients, physicians and third party payers. 
New chemotherapy agents, along with the addition of targeted agents, have 
already significantly improved median survival time and both one and two year survival 
times (Molina, 2006). Further efforts that are successful in preventing lung cancer, 
detecting lung cancer earlier or providing treatments that offer better outcomes, could 
help change the way we view and treat lung cancer, which today is as an aggressive, 
acute disease with a high mortality rate, shifting it towards a more chronically managed 
condition that patients may live with for decades. 
Due to the overwhelming mortality rates from lung cancer and possibly due to the 
stigma associated with the disease, there has not been a tremendous amount of 
information, research, and support developed for this particular group of cancer patients, 
their caregivers or their physicians. Over 75% of physicians felt that if the stigma of lung 
cancer being a self inflicted disease was not present, more patients would seek medical 
information and treatment (LungCancer.org, p 2). A simple internet search revealed 
twenty times more information readily available for breast cancer patients compared to 
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lung cancer patients. If patients are to playa more prominent role in the management of 
their disease, then we have to know more about what types of information they are asking 
for and what types of information they need in order to improve the patient / provider 
interaction in a chronic treatment setting. If gaps can be readily identified then a research 
agenda can be developed outlining areas most in need of funding. 
From 1999 to 2004, Congressional funding at the Department of Defense for 
breast cancer was almost $1.7 billion compared to $33 million for lung cancer over that 
same time frame. Over $200 million was allocated to the Center for Disease control in 
support of breast cancer research in 2005, while there was zero funding allocated to this 
group for lung cancer research that same year (Lung Cancer Alliance, pI). In 2004, 
$13,953 was spent on research for every breast cancer death versus $1,723 for every lung 
cancer death (LungCancer.org, p 3). Despite the fact that lung cancer remains the leading 
cause of cancer death, the amount of funding spent on research broken out per patient 
death provides further evidence that there has been very little attention devoted to 
learning about this particular group of cancer patients. 
Mapping what we do know and identifying gaps with regards to these patients is 
important for several reasons. Of the new lung cancer patients diagnosed each year, 
35%-40% are current smokers, 50% are former smokers and only 10% -15% are never 
smokers (Lung Cancer Alliance, pI). Understanding more about the treatment 
interactions and information needs of these patients is important due to the fact that lung 
cancer patients may be inherently different from other cancer patients in that the majority 
of lung patients engaged in smoking behavior, which is strongly associated with the 
development of the disease. This could have a profound impact with regards to the 
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potential long term interactions they may need to have with their oncologists and their 
treatment teams. 
Retrospective and prospective studies throughout the 1950' s began to report on 
the association between cigarette smoking and lung cancer. The 1964 Surgeon General's 
Report definitively concluded that smoking caused lung cancer (US Dept of Health 
Education and Welfare, 1964). And yet despite all the awareness of smoking related 
health risks, an estimated 45 million Americans are current smokers (American Cancer 
Society, p 36). The fact that the majority of lung cancer patients engage in behavior 
known to cause cancer, and that they subsequently face the stigma society attributes to 
smokers, may indicate a marked difference in their health literacy as well as their health 
beliefs, compared to other cancer patients, which will in turn impact their resource needs 
as they move through the medical system. Additionally, the treating physicians as well as 
caregivers may respond differently to these cancer patients and their disease management 
needs. 
Currently most lung cancer patients can be characterized as having an acute 
illness due to the severity and mortality associated with most lung cancer diagnoses. 
There may not be enough time in the treatment plan for patients to become very 
knowledgeable, aware and involved in their particular treatment plan. Conversely, 
patients with any chronic condition are generally encouraged to become more involved 
and more informed with regards their health care, their disease, their treatment options 
and their disease management. 
In response to a quality report from the Institute of Medicine, Wagner et aI, 
(2001) developed a chronic care illness model that served as a framework for 
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understanding system changes necessary to provide quality chronic care. While their 
model focuses on chronic care in the primary health care setting, the physical, mental and 
social challenges they identify for patients and caregivers are arguably applicable in any 
setting. Ultimately Wagner et ai, (2001) identify six "essential elements" overlapping 
the community, the healthcare system and the provider organization that must work 
together in order for quality chronic care to be delivered effectively. They identified the 
need for 1) linkages to community based resources, 2) appropriate culture within an 
organization that supports and rewards good chronic care, 3) self management support 
with the patient as an active participant, 4) adequate delivery systems and practice teams, 
5) evidence based decision support, and 6) clinical information systems to support and 
evaluate decision making (p 69). As supported by Wagner et ai, (2001) and outlined in 
the Institute of Medicine's Quality report, quality is likely to improve if the interaction 
between the patient and the treatment team can become more productive. 
Bodenheimer, Wagner and Grumbach (2002) assess that medical professionals 
must work to help patients and caregivers develop the skills as well as the motivation and 
confidence to selfmanage, set goals and follow up appropriately_ Oncologists who treat 
lung cancer patients must have a clear understanding of their potentially unique patient 
characteristics if they are to work in a collaborative and productive treatment 
environment. Based on Wagner's (2001) chronic care model, four components are 
critical for the thoracic treatment team to optimize during provider patient interactions: 
garnering patient perspective regarding the course and management of the illness, 
assisting the patient in goal setting and problem solving, applying clinical and behavioral 
interventions aimed at reducing complications and improving well being and finally to 
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ensure continuous follow up. It is unclear at this point as to how prepared oncologists are 
to organize and coordinate these types of interactions specifically for their patients 
diagnosed and treated for lung cancer. 
An essential question then becomes, what do we know and what do we need to 
know in order to successfully anticipate and meet lung cancer patients' needs in the 
chronic care setting? In order to better anticipate and meet the needs of these patients in 
the future, we must be able to determine what information patients need now and what 
questions they are asking now, as well as how they view their disease and make treatment 
decisions. We also need to understand what is known about how physicians treating 
these patients are able to anticipate and meet their needs and what challenges they must 
overcome in the future in order to do so in the chronic care setting. To do so we need a 
comprehensive model of the lung cancer of the future which incorporates what is known 
about cancer management from other more treatable cancers as well as what is known 
about the management of chronic diseases developed from the primary care setting. 
With both breast and prostate cancer, there has been a tremendous increase in 
patient awareness regarding screening guidelines, symptom development and treatment 
considerations, as well as an increase in the patients' self management of those disease 
states. In order for this to occur with lung cancer, we must better understand what 
commonalities and differences they may have with other patients who manage serious, 
chronic conditions for five to ten years following diagnosis as well as identify a research 
agenda to fill in gaps in our informational market analysis. 
We are on the verge of a paradigm shift with regards to the treatment model for 
lung cancer. The final step is to develop a comprehensive model that integrates what is 
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known from other cancers and adapt it specifically to lung cancer and the unique needs of 
those patients and their treating physicians. 
This project will encompass two main objectives. The first objective will be to 
complete an integrative mapping of the literature and information available regarding 
lung cancer patient characteristics as they relate to: 1) current lung cancer diagnosis and 
treatment considerations, obstacles and barriers, 2) lung cancer patients' health beliefs, 
therapy goals, treatment needs, and preferences as they relate to quality of life and well 
being, 3) availability and operability of lung cancer patients' support networks and 
caregiver needs, 4) current barriers and obstacles faced by these patients, including the 
stigma associated with being a smoker, and 5) identification of a future research agenda 
necessary to fill in all the knowledge gaps that would currently prevent the successful 
disease state management of lung cancer as a chronic condition as outlined in the chronic 
care model of disease management specifically as it relates to the physician-patient 
interaction. The integrative mapping of the relevant literature will in fact be a case study 
or market analysis of this patient population. In mapping what we know about the 
characteristics of lung cancer patients, their decision making, and their information needs, 
as well as their perceptions of their physicians and caregivers, I will develop several 
hypotheses regarding how we can better anticipate and meet the needs of this patient 
group as they relate to the chronic care model of illness. Additionally, this integrative 
knowledge mapping should elucidate several gaps in the literature regarding the specific 
health drivers related to this particular group of patients. 
The second objective will be to develop a theoretical model from the patient 
perspective that addresses both internal and external factors related to lung cancer 
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patients becoming active, motivated and engaged participants in their chronic health care 
management. This model will incorporate what is known about successful chronic care 
patient interactions and incorporate specific influences that may face those patients 
diagnosed with lung cancer. 
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rvtETHODS 
The first objective was to identify literature on the evidence and gaps with regards 
to our knowledge surrounding 1) the decision making process and health beliefs relating 
to lung cancer patients, their information needs and factors relating to their ultimate 
treatment decisions, 2) barriers relating to diagnosis, treatment and subsequent behavior 
interventions for lung cancer patients who are primarily smokers, 3) interventions and 
goals of therapy that improve patient care and / or outcomes for lung cancer patients 
diagnosed at both early and late stages of lung cancer, 4) tools and support services 
available to help patients become more informed, active participants in their care choices, 
and 5) information needed by clinicians to better coordinate and anticipate the care needs 
of lung cancer patients for longer periods of time. 
This research also identified where there was congruence with regards to 
physician perception of patient related goals and preferences versus actual patient goals 
and preferences, as well as the barriers faced in following through with recommended 
treatment protocols. Following this review, a knowledge map was developed that will 
later be useful in the knowledge transfer chain to providers, patients and health systems 
via the Chronic Care Model as well as in the development of a future research agenda. 
Knowledge mapping has been supported and developed over the last ten years by 
numerous health agencies, including the World Health Organization, and has been useful 
at the institutional level, the community level and the policy level (Ebener, et aI, 2006). 
Prostate cancer researchers at Dana Farber Cancer Institute in Boston, Massachussets, 
were successful in developing a knowledge map identifying the multiple domains of 
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inequality as well as their interactions and relative contributions (Gilligan, 2005). 
Through their development of a knowledge map, they were able to identify where there 
was inequality, the overall relevance of that inequality, as well as the subsequent 
identification ofa targeted research agenda. Alborz, McNally and Glendinning (2005) 
were successful in mapping the issues faced by people with learning disabilities as they 
related to healthcare access. The result of their mapping process was a modified access 
to care model that was patient specific for those with learning disabilities. Again, the 
mapping exercise allowed them to identify research gaps at both the macro and the micro 
level resulting in the identification of several strategies to overcome specific barriers. 
For this project, several data sources were identified and included bibliographic 
databases, organizational websites and library catalogues. Literature reviews were 
conducted using the following databases: Medline, CINHAL, PsychInfo, PubMed, and 
Cancer Lit. Only articles published in English were included in the review. Thesaurus 
terms were initially identified and searched in an integrative approach to identify the 
literature that pertains to the following research questions: ''what do we know about lung 
cancer patients, what do we know about how they make decisions, what do we know 
about their health beliefs, what do we know about their support systems, what do we 
know about their information needs as well as those of their caregiver networks, what do 
we know about their decision making and preferences regarding different therapy 
options, what questions are they asking now and what questions might they be asking in 
the future, and what do we know about how they communicate with their physicians or 
how they would like to communicate with their physicians in the future?" 
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The development of a search strategy was an iterative process that involved the 
following initial search and mapping of key terms followed by sequential searching based 
on the findings or lack thereof The following search terms were systematically reviewed 
both individually and combined: lung cancer, epidemiology, statistics, descriptive 
statistics, decision making, quality of life, health screening, cancer screening, health 
beliefs, smokers, non-smokers, smoking cessation, patient attitudes, patient navigators, 
patient expectations, health behavior, health promotion, health services accessibility, 
preventive health care, risk factors, diagnosis, symptoms, decision aids, decision support 
techniques, caregiver networks, barriers to care, barriers to access, chemotherapy, 
palliative care, patient education, attitude towards health, oncologists perceptions, 
adapting to cancer diagnosis, stigma, unrealistic optimism, information needs, 
information seeking, doctor-patient communication, therapy goals, follow up, and goal 
setting. 
Abstracts were then retrieved and reviewed for relevance. Original articles were 
then retrieved and grouped according to topic. References in each article were then hand 
searched to determine whether they should be included or to determine whether they led 
to new search terms to be used in the process. Free text searching also took place to 
identify any gaps in the search process. Research papers identified were then cross 
referenced for similar papers and papers citing the work in question. 
Quantitative and qualitative studies were included in the research review. Studies 
that involved lung cancer patients and patients at risk for lung cancer were the primary 
target during this review. However there was a need to include studies that involved 
cancer patients in general or patients facing end of life decisions since they provided 
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additional insight into the development of the model. The goal was to identify the 
population at risk, those diagnosed with lung cancer or those at risk for being diagnosed 
with lung cancer, and then to find out what information was available about those 
patients that mayor may not differentiate them from other cancer patients based on the 
fact that this is the singular cancer that arises primarily as a result of patient behavior 
deemed to be risky and self imposed. Additionally the goal was to assess the gaps in the 
literature regarding the care and needs specifically of lung cancer patients that need to be 
addressed in order for the model of care to move successfully from one of acute care to 
chronic care. 
Issues and concepts were identified that related to health beliefs, decision support, 
access to care, support networks, stigma, physician bias, and patient preferences, fears 
and misperceptions regarding the quality or outcome of various care options. Articles 
were included on smokers' attitudes towards health and risky behaviors, even though 
many of those articles did not include patients diagnosed with lung cancer. The rationale 
for this was that this patient population might have an unrealistic perception regarding the 
risk of smoking and therefore may have an unrealistic perception regarding the benefit of 
early diagnosis and various treatment options once they are potentially diagnosed with 
lung cancer. 
The literature searching was both an integrative and an iterative process that built 
upon itself based on what was discovered. A knowledge mapping framework was then 
developed that encompassed directional arrows representing hypothesized relationships 
based on our knowledge from other cancer patients and incorporating what was actually 
found regarding lung cancer patients specifically. 
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Rather than using a reference manager database, the entire search file was saved 
on the MUSe library search engine so that it could be continually evaluated for 
continuity, directional growth and additions to the literature over time. 
There are several limitations with this method of mapping. A limited number of 
studies specific to patients with lung cancer were identified in the literature review and 
there may be data that was not included or identified during the search process. 
Numerous studies were identified that provided information on cancer patients' beliefs 
and needs, and while those studies included lung cancer patients, their specific 
information was not usually stratified based on tumor type, tumor stage, prognosis or 
smoking status. The majority of studies that were reviewed had a small sample size of 
lung cancer patients, and usually included patients with advanced disease and poor 
prognosis. There were very few studies addressing lung cancer patients diagnosed early, 
presenting with a much better prognosis, who may have somewhat different attitudes 
towards future health decisions. Another limitation of this type of research is that based 
on the stigma related to lung cancer, a number of patients have not been identified as 
smokers, or have failed to acknowledge the role their behavior had in the development of 
their disease and often have failed to be forthcoming regarding their true behaviors or 
their expectations regarding their treatment methods, needs or outcomes. Given the fact 
that lung cancer survival rates are so low, many patients may not have been told of their 
true prognosis, many have not accepted their true prognosis and or many may not have 
actually had the time to make health behavior changes prior to their final mortality related 
outcome. However, the decision making process in this group of patients, regardless of 
whether it is based on a realistic expectation of the outcome, is very relevant given that 
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they are in fact making health care decisions in some cases without appropriate 
knowledge or true informed consent. 
Studies were not given a quality rating, as has been the case in other research 
using literature reviews, but were used to develop the mapping concepts and assess 
whether there is enough information to make a determination regarding a knowledge base 
versus a gap. Any data available was deemed relevant in developing the knowledge map, 
even if that ultimately represented a portion of the map that was more representative of a 
knowledge gap or an area deserving of further research and exploration. This created the 
opportunity to develop hypotheses for further testing. The quantity of the data for any 
given subject heading was ultimately helpful in determining whether there was in fact a 
knowledge base or a knowledge gap that should be further examined. 
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RESULTS 
The mapping process took place in two stages, the first of which occurred 
simultaneously with the information review. The first stage of knowledge mapping 
involved the development of the mapping domains along with a visual representation of 
their interrelationships. Initially several domains were identified and mapped on a white 
board. The starting point began with lung cancer patient characteristics and health beliefs 
specific to people who were current or former smokers. During the search for 
information, as new domains began to emerge they were added to the map. 
Upon checking the references in each article identified, new domains were often 
identified if they represented a knowledge base in another cancer type or another disease 
type even if there was not data representative of what was known in lung cancer. The 
identification of these domains then in turn led to the development of additional search 
criteria and subsequently additional mapping domains. 
Often the references in an article that pertained to another type of cancer were 
helpful in developing a mapping domain even if that domain ultimately represented a 
knowledge gap with regards to lung cancer patients. Reference checking was also helpful 
in identifying articles that did not initially appear under a specific lung cancer patient 
search but that included lung patient perspectives on topics such as communicating 
prognosis or decision making. This data was often embedded in a study dealing with 
numerous types of cancer patients. 
The second part of the mapping involved synthesizing the information for each 
given domain and developing an overall summary for each portion of the map. Initially 
articles were read for content and a summary paragraph of key learning was written for 
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each article. Article summaries were grouped and an overall summary was developed for 
each map domain. Map domains were ultimately characterized based on whether there 
was clear evidence, conflicting evidence or no evidence with regards to each topic. After 
information was synthesized, articles were numbered and counted based on whether or 
not they contributed to the overall information in one or more map domains. This 
information is depicted in table 1. Numerous articles contributed information to more 
than one map domain, which accounts for the fact that articles are referenced more than 
once in the table. 
Many papers represented information derived from a very small sample size, and 
while the papers themselves may not have been relevant, they were helpful in developing 
many of the mapping concepts that are still open for future research and development. 
Ultimately 141 studies were included based on the value of the data provided to enhance 
the development of a knowledge map and subsequent model development. Additionally, 
studies were included that provided insight into patient decision making based on their 
health status or their health behaviors leading up to a lung cancer diagnosis, which 
primarily included those dealing with smokers and risk, optimism or cessation 
interventions. Studies were also included that were literature reviews themselves, and in 
those cases, all of the articles were not reviewed separately if the overall conclusions 
could be ascertained from the primary review. 
The only texts that were excluded involved studies relating to factors regarding 
patient care or treatment outcomes that were outside the realm of individual patient 
decision making, beliefs or quality of life, such as those relating to improvements in 
genomics research, tumor staging, and treatment with investigational drug therapy. It 
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was assumed that these factors were more relevant to changes in actual treatment 
innovations, and they represented therapy related outcomes rather than patient choices, 
decision making, self management, QOL interventions, or information and 
communication needs. Additionally specific pharmaceutical studies related to drug 
efficacy were excluded because they provided little information regarding patient 
motivation or choice with the exception of studies that specifically addressed patient 
related choices based on quality of life measures when deciding between therapy options. 
The following summaries are representative of the information reviewed for each 
mapping domain that ultimately guided in understanding what we know about the 
specific characteristics of lung cancer patients with regards to how they make decisions 
regarding the management of their disease: 
Health Beliefs I Smokers 
In developing a clear understanding of how to manage lung cancer patients in a 
chronic care setting, it is important to understand their health beliefs may be different 
than those of other cancer patients, and as such, they may need to be managed with 
different considerations. F or years the detrimental effects of smoking have been well 
documented and publicized. Since the majority of patients with lung cancer have 
engaged in a behavior known to cause such cancer, their perception of risk and optimism 
may be different regarding health care, risks and benefits and medical decision making. 
Optimism and Risk 
Numerous studies show that smokers tend to be overly optimistic regarding their 
chance of developing a smoking related illness such as lung cancer as well as the 
possibility of cure in the event they do develop cancer. Smokers tend to attribute lung 
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cancer to a number of other factors outside of cigarette smoking and greatly 
underestimate their actual risk of developing lung cancer (Brownson, 1992; Dias, 2006; 
Dillard, 2006; Donovan, 2006; Dowding, 2006; Hay, 2005; Ma, 2002; Dncken, 2005; 
Salander, 2006; Silvestri, 2006; and Weinstein, 2005). Additionally smokers tend to 
overestimate the survivability of lung cancer and have false optimism about the cure rates 
(Dillard, 2006). 
This false optimism seen by smokers is also demonstrated at times by patients 
with lung cancer. Like smokers without cancer, lung cancer patients also overestimate 
the survivability (Weeks, 1998) and may also fail to recognize the benefits of quitting 
smoking even after being diagnosed with lung cancer. Studies have shown that the 
majority of lung cancer patients believed that lung cancer was curable when they were 
diagnosed, and less than 10% of those patients knew that their life expectancy was less 
than one year (Malin, 2006). This is a very different thought process than what is seen 
with other at risk cancer patients, such as with those at risk for breast cancer, who are 
often overly pessimistic and think their prognosis is much worse than expected (Lipkus, 
2001). 
This misperception or denial of risk and false optimism seen in smokers and also 
in lung cancer patients may be particularly important for physicians to understand as they 
are trying to communicate accurate risks and expected outcomes of various therapy 
choices so they can work jointly with patients to play an active role in deciding how to 
manage disease (Cykert, 2004; and The, 2000). It is also important in thinking forward 
regarding future health behavior interventions that if patients in fact end up surviving 
lung cancer for longer periods of time, then their false optimism may seem justified in 
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their mind. This might make it difficult for physicians to convince them of the 
importance of preventing future health complications or modify health behavior. 
Stigma 
Several studies and surveys have reported on and hypothesized about the role that 
stigma as it relates to smoking and its cause and effect relationship with lung cancer may 
play with regards to low funding levels for lung cancer research. Additionally, the stigma 
that many lung cancer patients feel from community, friends, family and health care 
providers may also playa role in their decision to seek medical help, which in tum can 
delay diagnosis and treatment (Chapple, 2004). Studies have found that smokers often 
feel unworthy of care (Street, 2004 and Corner 2005) and are ashamed and embarrassed 
to tell people of their smoking related illness. This in tum could lead to a decreased use 
of community based resources aimed at support, behavioral interventions, and outreach. 
Additionally, the stigma faced by some may in fact prevent them from recognizing or 
accepting the role smoking played in the development of their lung cancer (Chapple, 
2004). This inability to look at cause and effect may impact patients' future decisions or 
attempts to try to quit smoking as many lung cancer patients never accept the fact that 
smoking behavior was related to their lung cancer diagnosis. 
Access 
Several studies indicate that socioeconomic status, insurance status and geography 
playa role in decreasing patients' access to care, resulting in poorer outcomes (Campbell, 
2001; Earle, 2002; Hall, 2004; and Silverstein, 2002). This may account for some of the 
disparities in survival seen with African American patients (Ferguson, 2003; Holzman, 
1995; and McDavid, 2003). However, other data suggests that when access was 
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universal, there were no differences in outcomes (Mulligan, 2006). One factor that has 
not been studied that must be addressed is service capacity as it relates to access. If lung 
cancer patients have increased survival rates, there will be a tremendous increase in the 
number of patients being managed in the system. It is unclear what impact this will have 
on physicians, nursing staff and the multidisciplinary treatment team. If lung cancer 
survival increased by twelve months, over 150,000 patients would remain in the system 
in the first year alone. These patients would need three or four follow up visits during 
that year. Access might be limited based on the number of providers and support staff, 
and lengthy delays in follow up care or in new patient visits could occur. Economic and 
feasibility studies need to be done to see what changes must be made in the system in 
order to meet access needs if there is an increase in demand. 
Diagnosis and Treatment Delay 
Lung cancer patients as a group have a much higher likelihood of individuals 
delaying diagnosis or treatment versus those with other cancers. While there is limited 
data on both patient as well as physician delay, preliminary evidence suggests that the 
majority of patients delay seeking help by more than three months (Salomaa, 2005). As 
discussed above, several studies have reported on the role that stigma and feelings of 
guilt that led to patients' feeling unworthy of care resulted in delays in seeking medical 
attention, thus delaying diagnosis and treatment. Additionally, numerous studies report a 
general lack of understanding and awareness regarding the early warning symptoms of 
lung cancer that should in fact prompt patients' to seek help (Comer, 2005 and 
Levealahti, 2006). While there is almost universal awareness regarding breast self exams 
and the need to get suspicious changes or lumps checked by a physician, it has been 
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estimated that more than half of smokers fail to identify symptoms of lung cancer 
(O'Conaill,2005). Patients in several studies reported having symptoms for months or 
years prior to the diagnosis of lung cancer, but often felt the symptoms weren't serious 
enough to warrant medical care, were related to their other health comorbidities rather 
than a new, more serious condition, or were simply part of getting older (Comer, 2005; 
Comer, 2005; and Levealahti, 2006). 
This represents a serious need for awareness campaigns that educate smokers 
about the early signs and symptoms of lung cancer. 
Disease Management / Treatment Decision Making 
In order for any patient to be actively involved in the decisions regarding 
treatment, they have to be well informed and have a clear understanding of the treatment, 
the expectations or goals, the risks, side effects and alternatives. Studies have 
documented wide variability in treatment choice among lung cancer patients based on 
cure, response, toxicity, prognosis, and symptom relief (Hirose, 2005; Markman, 2006; 
Matsuyama, 2006; Silverstri, 1998; and Skinn, 1994). Data suggests that most lung 
cancer patients want a collaborative role in making treatment decisions (Davidson, 1999). 
They also need specific information regarding details of the therapy, anticipated early and 
later side effects, survival estimates, and symptom relief to make choices consistent with 
their beliefs (Feldman-Stewart, 2004; Sorensen, 2004; and Weeks, 1998). However, 
studies have shown that fewer than half of lung cancer patients being treated ever had a 
discussion with their physician about therapy choices or about selecting therapy based on 
side effect profiles (Dubey, 2005). Physician goals of therapy agreed with patient goals 
of therapy only 50% of the time in one study (Chu, 2007), and other data suggests that 
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fewer than 25% of patients would choose their same treatment again, indicating a lack of 
clear communication and understanding between physician and patient (Krishnasamy, 
2001; Quirt, 1997; and Silvestri, 1998). 
Understanding how lung cancer patients make decisions is critical given their 
health beliefs, risk assessments and often unrealistic optimism. A number of factors 
including race, ethnicity, age, spirituality, coping skills, and familial support have been 
identified as having an impact on lung cancer patients' treatment decision making process 
(Lathan, 2006; Markman, 2006; Margolis, 2003; Sharf, 2005; Silvestri, 2003; Siminoff, 
2006; and True, 2005). While their specific impact or role in decision making is not fully 
known, physicians often failed to recognize them as being important factors to consider 
when talking with patients about therapy options, and data suggests that treatment teams 
failed to improve the quality of decision making versus that of individual physicians 
(Kee, 2004). 
Numerous studies have shown that decision aids are effective in helping lung 
cancer patients increase their knowledge as well as make therapy choices that reflect their 
true values and desires (Brundage, 1998, 2000, 2001; Fiset, 2000; and Leighl, 2004). 
However, there is no clear standard as to the content that should be included and patients' 
needs and comprehension skills vary widely. It has also proven difficult to include risk 
assessments in an accurate manner given smokers' beliefs regarding risk versus non 
smokers' beliefs regarding risks (Feldman-Stewart, 2004). There is data that suggests 
that lung cancer patients are in fact willing to accept small benefits with big risks more so 
than other patients (Cykert, 2004; Hirose, 2005; and Matsuyama, 2006). Physicians 
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should be aware of the differences in risk perception among smokers, and thus most of 
their lung cancer patients. 
Communication 
Since risk decisions can only be made with accurate information, physicians are 
often at a loss as to how to communicate risk to lung cancer patients who, as a group 
made up primarily of smokers, tend to make unrealistic risk assessments. There is little 
information regarding communication needs and preferences with lung cancer patients 
specifically, yet limited data suggests that patients who receive diagnosis and information 
from a specialist are more likely to be clear on the disease specifics (Krishnasamy, 2001). 
The fact that several studies showed wide disagreement with regards to patient and 
physician stated therapy goals, actual therapy choices or expected prognosis shows that 
this is an area for future research (Chu, 2007; Quirt, 1997; Sharf, 2005; Weeks, 1998; and 
Yardley, 2001). Numerous studies exist with breast cancer patients regarding the 
communication preferences regarding prognosis and therapy and data suggests this may 
vary by tumor type (Hagerty, 2005). Studies need to be done with lung cancer patients 
specifically. 
Physicians must recognize that patients have attachment needs and that in order to 
include them in the decision making process, they must establish a relationship and trust 
(Cykert, 2004) and in some cases starting that communication prior to the first patient 
visit was viewed as positive (Quinn, 2007). This may be particularly true when dealing 
with African American patients who reported lower levels of trust based on their 
perception of poor physician communication (Gordon, 2006). Patients' desires for 
increased communication or information may in fact be an increased need for relationship 
24 
building and further communication on the part of the physician (Salandar, 2005 and 
Sharf, 2005). Physician communication style was seen as one of the strongest predictors 
of patient participation during the consultation (Street, 2005). Physicians who used more 
supportive and partnership building communication styles had patients with increased 
levels of participation (Street, 2006). Whether this type of communication style is widely 
used by oncologists is currently unknown. 
Information 
Lung cancer patients get their information from a variety of sources both formal 
and informal, however the quality and completeness of that information is often low 
(Mat suyama, 2006). However, patients often overrate the quality of the information they 
receive from sources other than their physician (peterson, 2003). There is a lack of 
information available that addresses survivability or treatment success (Donovan, 2006 
and Matsuyama, 2006), and this is often the type of information patients ask for and need 
in order to make informed choices. Additionally data suggests that much of the 
information available needs to be written at lower reading level in order to be useful to 
the majority of lung cancer patients (powers, 2006). Most data showed that lung cancer 
patients wanted and needed detailed, specific information in order for them to participate 
with a high level of involvement (Davidson, 1999 and Sorensen, 2004). 
There was evidence that race may also playa role in the amount of information 
lung cancer patients receive from their physician. Sometimes black patients received less 
information from their physicians. It is unclear as to why this is the case, however it 
could be related to the fact that black patients often participated less frequently and were 
less likely to bring a companion with them during their consultation versus white lung 
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cancer patients (Gordon, 2006). Limited data exists regarding the role race and ethnicity 
play on the preferred information venue with cancer patients in general, with data from 
one study suggestive of white patients preferring medical journals, telephone and internet 
sources, Japanese patients preferring media and commercial sources of information, and 
other Asian patients preferring personal communication with physicians, peers and social 
groups (Kakai, 2003). 
The internet was the most common source of information for lung cancer patients 
outside their physician (peterson, 2003), however there are no studies measuring the 
effectiveness of internet education in lung cancer. Lung cancer patients who used the 
internet expressed strong interest in participating in clinical trials (Markman, 2005), and 
smokers who used the internet expressed greater interest in quitting smoking (Stoddard, 
2006). 
It is important to recognize that lung cancer patients' information needs may 
change over the course of their illness and their preferred method of communication may 
change as well (Moore, 2006). Patients seemed to express interest and satisfaction using 
e-mail and telephone calls for advice, information and follow up (Moore, 2004). Further 
investigation into the information and resource needs of lung cancer patients is warranted 
and should also try to illuminate further information regarding the specific needs of 
different ethnic and minority groups. 
Problem Solving 
Patients managed in the chronic care setting must partner with their provider so 
that can be actively involved in problem solving. There was no data available to 
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determine lung cancer patients' preferences or abilities to problem solve in an acute or 
chronic care environment. 
Goal Setting 
No data exists on how lung cancer patients and physicians work together to set 
realistic goals related to patients' treatment, behavioral interventions and follow up plans. 
Lung cancer patient advocacy groups were limited with their information on patient 
expectations. Data showed that when breast cancer patients used a combination of 
physical and psychological interventions, including goal setting, they were better able to 
manage chronic pain (Robb, 2006). Patients in a general cancer population were most 
likely to set rehabilitation goals to improve self care, leisure activities and productivity 
(Watterson, 2004). These goals were rated as equally important to the patient. There is 
also data suggesting that in the general cancer population, misdirected goal setting was 
associated with increases in depression (Street, 2003). 
There is clear need for further research involving lung cancer patients and their 
ability to set and meet both short term and long term treatment, intervent.ional and follow 
up goals. Additionally, studies to outline appropriate goals are necessary so that patients 
can have a clear understanding of which goals might be realistic and appropriate for their 
given care plan. Although hospice patients are in a terminal phase, it is possible that we 
could learn from the body of evidence regarding how those patients, including lung 
cancer patients, set goals with regards to physical, emotional or spiritual needs at the end 
ofHfe and apply this information in a more chronic phase (pizzi, 2004). 
Self Management 
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There was limited information regarding how to help lung cancer patients take a 
more active role in self managing their disease, their symptoms and their quality of life. 
Numerous studies did show that patients who were directly involved in managing their 
care had improved quality of life scores, and that those patients also exhibited a strong 
awareness of resources, had strong self efficacy beliefs and lower anxiety or depression 
versus other lung cancer patients (Boehmer, 2007; Downe-Wamboldt, 2006; and Maliski, 
2003). Additionally, several studies found that patients using complementary or 
alternative medicine were more likely to be involved in self management and considered 
their use of those therapies as a positive step towards fighting cancer (F ouladbakhsh, 
2005 and Molassiotis, 2006). There was conflicting evidence regarding how well 
caregivers were able to assess a patient's ability to self manage, with some studies 
showing that caregivers over rated patients' abilities while others showed that they 
underestimated patients' abilities (Madison, 1995 and Porter, 2002). 
This indicates a need for treatment teams to help patients understand all the 
resources available, and to assess and treat depression and anxiety as quickly as possible 
in order for the patient to optimize self management skills. Furthermore, the studies 
represented here indicate a need for further research aimed at helping the physician assess 
patients' abilities more accurately rather than using surrogate assessments from 
caregivers. Further work needs to be done to detennine which types of interventions are 
most helpful in increasing lung cancer patients self efficacy beliefs and coping skills. 
Follow Up 
There is a lack of general consensus on how to follow up with lung cancer 
patients using evidence based guidelines that ensure quality care that is cost effective 
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(Saunders, 2003). Studies indicate there is a need for patients to have access to the well 
informed, multidisciplinary treatment teams, but no clear measure of how to do this 
effectively. The follow-up expectations that are in place focus solely on follow up for 
acute lung cancer, and there are not any specific recommendations for chronic care 
management or coordination (Smith, 2003). 
Several studies showed that patients were willing to follow up with the help of 
nursing led clinics or interventions and that up to 20% of all follow up might be 
appropriately led by nurses, particularly if the follow up involved physical or 
psychological needs (Cox, 2006). Training and support needs have been preliminarily 
outlined for these demanding roles and further implementation guidelines are necessary. 
Lung cancer patients expressed satisfaction with nursing follow up services in person and 
via telephone as they transitioned from active care to follow up care (Moore, 2006). 
There is a clear need for more information regarding cost effective follow up care 
that takes into account the comorbidities and health behavior interventions necessary for 
lung cancer patients to lead longer, more productive lives. There is no clear cut method 
for providing, developing or coordinating follow up care plans. 
Ouality of life / Well being 
Maintaining a good quality of life is important for all cancer patients, and health 
related quality of life domains of importance differ by tumor type (Osoba, 2006) and may 
prove to have inherent prognostic value (Maione, 2005). It is important to identify the 
many needs of lung cancer patients and their support groups or caregivers, prior to the 
start of therapy, as these patients present with greater psychological and physical burden 
compared to most other cancers (Bozcuk, 2006 and Ko, 2003), and persistent smoking 
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often decreases quality of life even further among this group of patients (Garces, 2006). 
A review of the literature revealed that there is no clear cut evidence regarding who is 
best qualified to lead, manage or coordinate behavioral interventions aimed at improving 
well being and quality of life for lung cancer patients (Thompson, 2005). This 
illuminates a need for research into whether patient navigators, thoracic nurse specialists 
or another member of the multidisciplinary team should take on this responsibility_ 
Psychosocial 
Lung cancer survivors may have more physical and psychosocial needs than other 
cancer survivors (Schag, 1994), and yet they often feel that their psychosocial issues are 
not being addressed by their provider, and this often leads to distress. These needs are 
expressed by caregivers as well (Li, 2006). Social constraints among spouses including 
denial, conflict, and criticism can lead to increased distress (Badr, 2006). Less than half 
of lung cancer patients felt that their concerns had been discussed with their healthcare 
team, and psychosocial issues were the ones most often overlooked (Hill, 2003). 
Improving physicians' understanding of specific patient concerns as well as the addition 
of psychosocial interventions may improve quality of life scores (Montazeri, 1998) 
EmotionallPsychological 
From a quality of life perspective, lung cancer patients exhibit some of the highest 
levels of emotional and psychological distress of any cancer patient group (Li, 2006; 
Lidstone, 2003; Walker, 2006; and Zabora, 2001). Feelings of anger may be more 
prevalent among this group of cancer patients versus others. Interestingly, some studies 
showed that this level of psychological distress was not correlated with a lack of family 
support or religion as might be expected (Kuo, 2002). Younger patients seemed to 
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experience greater levels of distress than older patients (Graves, 2007), and those patients 
who used adaptive coping skills along with problem focused coping skills tended to 
improve more so than those who used emotion focused coping strategies (Kuo, 2002 and 
Walker, 2006). There was also a positive correlation between increased symptom distress 
and increased emotional distress, underscoring the need to address all aspects of lung 
cancer patients' physical and psychological concerns jointly (Montazeri, 2003). 
Additionally, the fact that some types of coping skills work better than others, indicates a 
need for physicians and support team members to be aware of which types of coping 
skills patients might typically use versus those they may need to be taught. 
Spiritual 
Several studies have shown that for lung cancer patients, spirituality plays an 
important role in both decision making as well as in quality of life, and in one study it 
ranked second only behind oncologists' recommendations in helping patients make 
critical decisions (Silvestri, 2003). However, the spiritual needs of patients and their 
caregivers are often not taken into account by physicians (Murray, 2004). Spirituality 
had a positive effect on physical and psychological quality of life for lung cancer patients 
(Meraviglia, 2004) and led to less depression in spouses who used moderate religious 
coping skills with patients (Abernethy, 2002). Physicians need to be aware that 
spirituality and coping skills often differ by ethnicity and race and that this may lead 
patients to make different choices than recommended or expected (True, 2005). One 
study compared lung cancer patients with heart failure patients and found spiritual needs 
to be different based on the different disease trajectories (Murray, 2002). This could raise 
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future questions regarding the spiritual needs of lung cancer patients if it becomes a more 
chronic condition with a disease trajectory more similar to cardiac failure. 
Depression! Anxiety 
Studies estimate that as many as one third to half of all lung cancer patients 
experience depression during the course of their illness and this rate may be higher than 
for most other cancer patients (Carlsen, 2005; Krishnasamy, 2001; Sarna, 2005; and 
Walker, 2006). Often this depression goes undiagnosed by the treating oncologist. 
Studies show there are also discrepancies in physician and patient reported levels of 
anxiety (Krishnasamy, 2001). Recognizing and treating depression early in this group of 
patients has been successful (Carlsen, 2005), and it is critical for chronic care 
management due to the relationship between depression and quality of life, symptom 
management and the patients' ability to participate successfully in health behavior 
interventions (Fox, 2006). Lung cancer patients who are depressed have decreased 
quality of life scores, report increased levels of fatigue as well as increased likelihood of 
smoking relapse (Walker, 2004). While depression itselfwas not related to decreased 
survival rates, those patients who used depressive coping skills did have decreased 
survival (Faller, 2004). Additionally, studies of patients with chronic diseases have 
shown that in patients with chronic disease the addition of depression resulted in a 
doubling of the use of acute services (Himelhoch, 2004). Oncologists need to screen, 
identify and treat depression early in all their lung cancer patients. 
Support Networks / Caregivers 
The support networks available to cancer patients playa vital role in helping those 
patients cope with and manage their disease. There is very little information regarding 
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the specific supportive care needs of lung cancer patients or how their support networks 
help meet those needs. There is data to suggest that lung cancer patients compared with 
other cancer patients have a greater number of un met psychological, physical and daily 
needs, many of which are not recognized by the caregivers (Broberger, 2005; Lidstone, 
2003; and Madison, 1995). This may be related to the fact that they present with more 
comorbidities, a greater likelihood of depression and possibly fail to seek support due to 
the stigma they feel as a result of their disease. Limited information suggests that fewer 
than half of lung cancer patients were able to get the help they needed from community 
based services, while physicians often underestimate the available support for patients 
(Krishnasamy, 2001 and Sharpe, 2005). 
Caregivers of lung cancer patients often take on a great burden in caring for these 
patients, and they are also at risk for decreased quality of life and depression (Downe-
Wamboldt, 2006; Sarna, 2006; and Pinquart, 2005). Studies have shown that family 
members often feel the impact of the patient's fatigue even more so than the patient 
(Hamilton, 2001). Reducing caregiver burden was shown to be more important than 
increasing social services in at least one study (Kim, 2005). Interventions that aided the 
caregiver in learning about the disease, treatments, and problem solving or coping skills 
reduced their burden (Abernethy, 2002). Further information needs to be gained 
regarding the coping skills that could be useful in reducing caregiver depression and 
quality of life so that they can he better positioned to help the lung cancer patient. 
Health Behavior Interventions 
Numerous health behavior interventions have been identified that enable cancer 
survivors to live healthy lives with improved quality ofHfe scores (Hately, 2003; Ryan, 
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1996; andThompson, 2005). However, most cancer patients don't receive this guidance 
from their oncologist. One review found that fewer than 20010 of oncologists give their 
patients guidance on health behavior interventions aimed at improving health and 
decreasing risk of other progressive diseases (Denmark-Wahnefried, 2005). These types 
of interventions will apply more frequently to lung cancer patients in the future should 
their life expectancy increase and they become managed like patients with other chronic 
conditions. This is particularly true for lung cancer patients because they tend to have 
decreased quality of life scores versus other cancer patients along with a heavier burden 
of illness (Sugimura, 2006). The impact of comorbid conditions on lung cancer 
survivability is currently unknown. This represents a change in the types of health 
concerns oncologists will need to manage with their lung cancer survivors in the future. 
In patients with lung cancer, there is no clear data on who is most qualified to coordinate 
or lead these jnterventions from the multidisciplinary team, although there are several 
studies indicating that many health behavior interventions can be and should be led by 
qualified nurses. 
Smoking Cessation 
There is a wealth of published information on smoking cessation, behavioral 
interventions, and relapse in the general population, which won't be discussed in detail 
here. Given the fact that 90010 of lung cancer patients are current or former smokers, 
smoking cessation in this specific group of patients is particularly important. Many 
oncologists agree that given the short prognosis, smoking cessation is often not a primary 
concern even though smoking cessation improved performance status in at least one 
group of lung cancer patients (Baser, 2006). One study showed that only 25% of lung 
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cancer patients were told by their physician that they needed to quit smoking following a 
diagnosis of lung cancer (Evangelista, 2003). Various studies show that a number of lung 
cancer patients who are smoking at the time of diagnosis continue smoking during or 
after treatment (Cox, 2002; and Schnoll, 2003). 
Relapse rates among quitters was also high, with as many as 40% of patients 
relapsing after one year and 60% relapsing after two years (Walker, 2004). Relapse 
seems to occur most frequently after only two months (Walker, 2004, 2006), and most 
often by those who failed to admit the role tobacco played in the development of their 
illness (Schnoll, 2002, 2004). Relapse was also high among patients who waited until 
surgery to quit smoking (Walker, 2004, 2006) as well as among patients whose family 
members continued to smoke. 
There is little data regarding which types of programs are most effective for lung 
cancer patients, but data points towards a combination of behavioral conditioning and 
reinforcement strategies (Schnoll, 2002). There is information that indicates that patients 
who are most likely to decline smoking cessation interventions altogether include those 
with fewer physical symptoms and those who are light smokers (Schnoll, 2004). 
Regardless of the type of program, many physician led smoking interventions were not 
effective, indicating a need for identifying effective smoking cessation programs led by 
others (Gritz, 1993; Schnoll, 2003). 
Given the totality of the health risks and the comorbidity associated with 
smoking, in the chronic care setting smoking cessation will become more important for 
those patients expecting to survive lung cancer for several years. As many smokers cling 
to myths regarding the impact of smoking on health (Dillard, 2006), physicians must 
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focus their efforts on getting patients to understand the benefits of smoking cessation as it 
relates to lung cancer as well as other health conditions. 
Physical Interventions 
There is very limited data on the successful implementation of behavioral 
interventions to increase physical activity with cancer patients in general and none were 
found relating to lung cancer patients. Yet this is an important variable given the limited 
evidence suggesting that lung cancer patients may have a higher number of physical 
symptoms and concerns versus other cancer patients. Studies show women with lung 
cancer may present with worse physical functioning than women with other cancers 
(Doorenbos, 2006), and that lung cancer patients' physical mobility generally declines 
after treatment. Data from the American Cancer Society is very limited and only 
includes a recommendation that lung cancer survivors increase physical activity (Ashley, 
2005). Limited information shows that interventions improving physical functioning in 
other cancer patients improved quality of life (Smith, 1996) as well as patients' ability to 
manage pain (Robb, 2006). This information needs to be determined in the lung cancer 
population. 
Alcohol/Nutrition 
There is very limited data regarding behavioral interventions designed to improve 
dietary habits and alcohol intake among cancer patients in general and even less 
information specific to lung cancer patients. Given the short prognosis for lung cancer, 
this has not been a concern for most oncologists. However, data suggests a correlation 
between alcohol use and smoking, therefore information on patients' alcohol use is most 
likely going to be an important factor during the management of lung cancer patients in 
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the chronic care setting. Data from one study suggests that almost 60% of long term lung 
cancer survivors continued their use of alcohol and that SO % of long term lung cancer 
survivors were overweight five years post treatment (Evangelista, 2003). Data from the 
American Cancer Society ifvery limited at best, recommending only that it is probably 
beneficial for lung cancer survivors to maintain a healthy weight and to increase fruit and 
vegetable intake (Ashley, 2005). There are no recommendations regarding how patients 
should accomplish this, and yet there is data that nutritional status is often already 
compromised when patients present with lung cancer diagnosis (Beach, 2001) and that 
status worsens during treatment. 
There is a need for understanding which behavioral interventions work as well as 
a need to determine how to present these interventions and gain agreement from patients 
regarding their impact and importance. Additionally, as family members often continue 
to drink, there may be a need to target them along with the patient (Sarna, 2006). 
Comorbidities 
Numerous studies have reported on and identified the comorbidities associated 
with lung cancer that are often attributed to smoking. Lung cancer patients have an 
extremely high incidence of comorbidity, with almost 90010 of patients presenting with at 
least one and 50% of patients presenting with three or more comorbid conditions 
(Tammemagi,2004). The presence of com or bid conditions in lung cancer patients has 
been shown to be predictive of lower health utility scores (1<0,2003; Sugimura, 2006). 
While some studies have failed to show an association between comorbidity and survival, 
others have shown that survival is adversely effected independent of treatment, thus 
leaving it unclear as to the true impact comorbid conditions may have on long term 
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survival (Sugimura, 2006; Tammemagi, 2004). There is no data regarding the 
management or follow up of these comorbid conditions in lung cancer patients and there 
are no current recommendations. 
Symptom Management 
Symptom management and therapy side effect management is critical for all 
cancer patients, however given the heavy burden of illness seen with lung cancer patients, 
it is vital for physicians to understand the distress felt by their patients, along with an 
understanding of their primary concerns (Dubey, 2005; Hsu, 2003; Lidstone, 2003). 
Fatigue, pain and depression and breathlessness are the most common symptoms 
experienced by lung cancer patients (Kiteley, 2006; Kuo, 2002; Lidstone, 2003), and 
while there is often agreement between the patient and physician regarding symptoms 
experienced (Basch, 2006), several studies showed that both physicians and caregivers or 
family members often overrated or underrated lung cancer patients' symptoms 
(Broberger, 2005; Lobchuk, 2006; Madison, 1995). Lung cancer patients often used 
complementary or alternative medicine to control or alleviate symptoms and this varied 
widely based on gender, age and geography (Fouladbakhsh, 2005; Wells, 2007). Patients 
often learned of these methods through family, friends and other lung cancer patients. 
The lack of data regarding symptom management once the patient is out of the acute 
phase underscores the need for interventions for both patients and caregivers. 
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DISCUSSION 
A visual model representing the factors that could influence or could represent 
what is necessary for a more active and informed lung cancer patient was developed (Fig 
2). This model is adapted from and incorporates elements of Wagner's (2001) chronic 
care model that specifically relate to the patient side of the physician - patient interaction. 
Four key components detailed in Wagner's model that are necessary for an active, 
informed patient participant in the chronic care setting serve as the core, central theme in 
this model, and are critical in order for lung cancer patients to playa role in managing 
their own chronic health care needs. These four themes can be thought of as internal in 
the context that they relate to individual patients and their knowledge, how they process 
that knowledge to make decisions, how they internally take responsibility for self 
management, how they internalize quality of life measures as well as apply QOL 
interventions, and how they accept responsibility for follow up care. The model itself 
should be viewed as cyclical rather than static, in that during each stage of chronic care 
management, or during new acute stages, the patient should be expected to go through the 
same circle or thought process. 
The outer portion of the circle represents the various external factors that may 
influence or place strain on the patients in their attempt to play an active, informed role. 
The factors include community communication and information transfer examples of 
which are literacy levels of information, technology available to deliver and receive 
information, venue of communication, and lack of prepared patient information. 
Examples of community based barriers include geography, finances, physical limitations, 
and service capacity. Examples of community support networks that need to be 
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considered are the availability of caregivers, community support groups, outreach and 
advocacy groups. Finally the community health beliefs that may exert influence on the 
patient include stigma, anti-smoking legislation, and media influence. 
Future research should focus not on the internal or the external components 
individually, but should reflect the impact they may have with one another. For example, 
it is difficult to assess appropriate follow up care plans without also assessing how lung 
cancer patients want to communicate regarding follow up, how their support network can 
assist them with follow up, and what barriers might exist that prevent them from actively 
participating in their follow up plan on a routine basis. 
This model represents the fact that in order to prepare the market place for a more 
chronic version of lung cancer, numerous research questions must be addressed and 
explored in order to develop an appropriate strategy that aids lung cancer patients in 
becoming both informed and motivated to a level where they can actively participate in 
their health care decisions over a prolonged period of time. 
In this mapping exercise I have tried to address the following questions: 
1) what do we know about lung cancer patients' health beliefs and how 
does that influence their decision making regarding treatment decisions 
and quality of life 
2) what do we know about lung cancer patients' and their communication 
and information preferences including both physician communication 
and preferred information seeking methods and tools 
3) what do we know about lung cancer patient support systems both 
internally and externally driven 
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4) what do we know about specific barriers faced by patients with lung 
cancer with regards to managing their health needs 
The interrelationship of these themes with the chronic care model has been 
incorporated into the new model representing the dynamics that should be considered 
when assessing lung cancer patients' readiness to participate in a productive chronic care 
relationship with their oncologist. This patient oriented model represents the first step 
towards developing a more extensive assessment of chronic care lung cancer treatment. 
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CONCLUSION 
This integrative research study has identified 23 individual factors that are known 
to encompass the individual building blocks needed to move the management of lung 
cancer from the current acute, terminal care mode towards a chronic care model. This 
review indicates that much research needs to be done before we can begin to successfully 
manage lung cancer as a chronic disease. In only three of the 23 areas do we have good 
information related to lung cancer, and in no case is information at the level of 
excellence. In three areas, there is good evidence in general cancer, but not specifically 
for lung cancer, and in the remaining 17 areas there is inadequate or no evidence. 
Given the current level of funding for lung cancer research, it is unlikely that we 
will be able to gain evidence in the near future. Thus, the promises for long term survival 
that are emerging from screening and treatment advances are unlikely to come to fruition 
for patients under real practice conditions unless a major change in research funding for 
lung cancer occurs soon. This study provides information on the building blocks needed 
to move lung cancer care into the future. It is imperative that research on these building 
blocks for future lung cancer care is recognized by leaders in the field and receive 
attention and funding. Without this evidence we can not move forward in caring for lung 
cancer patients. 
In assessing the knowledge gaps or discrepancies identified in this knowledge 
mapping exercise, two important areas to address that would have an immediate impact 
on patients now and in the future are identified. There is clearly a need for better tools to 
help improve communication regarding treatment options and goals so that there is 
improved understanding at the patient level and improved agreement between patients 
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and physicians regarding the actual expectations from therapy. Secondly the gap in 
identifying and treating depression in this group of patients must be addressed to improve 
quality of life in both the short term and the long term for acute and chronically treated 
lung cancer patients. 
In addition to the research gaps identified in the knowledge mapping exercise, the 
next research need to be addressed in the future should involve a focus how physicians 
treating lung cancer can prepare for more productive physician-patient interactions and 
relationships. We must understand physician perceptions regarding their readiness to 
participate in and manage lung cancer patients through a much more prolonged series of 
productive physician patient interactions, as well as identifying their perceived barriers to 
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